Vis enkel innførsel

dc.contributor.authorMisawa, Takuma
dc.contributor.authorWagner, Marek
dc.contributor.authorKoyasu, Shigeo
dc.date.accessioned2023-03-15T13:00:48Z
dc.date.available2023-03-15T13:00:48Z
dc.date.created2022-09-28T08:25:39Z
dc.date.issued2022
dc.identifier.issn1664-3224
dc.identifier.urihttps://hdl.handle.net/11250/3058445
dc.description.abstractGroup 2 innate lymphoid cells (ILC2s) were initially identified as a new type of lymphocytes that produce vigorous amounts of type 2 cytokines in adipose tissue. Subsequent studies revealed that ILC2s are present not only in adipose tissue but also in various other tissues such as lung and skin. ILC2s are generally recognized as tissue-resident immune cells that regulate tissue homeostasis. ILC2s express receptors for various humoral factors and thus can change their functions or distribution depending on the environment and circumstances. In this review, we will outline our recent understanding of ILC2 biology and discuss future directions for ILC2 research, particularly in adipose tissue and metabolic homeostasis.en_US
dc.language.isoengen_US
dc.publisherFrontiersen_US
dc.rightsNavngivelse 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/deed.no*
dc.titleILC2s and Adipose Tissue Homeostasis: Progress to Date and the Road Aheaden_US
dc.typeJournal articleen_US
dc.typePeer revieweden_US
dc.description.versionpublishedVersionen_US
dc.rights.holderCopyright 2022 The Author(s)en_US
dc.source.articlenumber876029en_US
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1
dc.identifier.doi10.3389/fimmu.2022.876029
dc.identifier.cristin2056131
dc.source.journalFrontiers in Immunologyen_US
dc.identifier.citationFrontiers in Immunology. 2022, 13, 876029.en_US
dc.source.volume13en_US


Tilhørende fil(er)

Thumbnail

Denne innførselen finnes i følgende samling(er)

Vis enkel innførsel

Navngivelse 4.0 Internasjonal
Med mindre annet er angitt, så er denne innførselen lisensiert som Navngivelse 4.0 Internasjonal